Health Canada warns of mislabeled drug
Posted on: Monday, 18 May 2009, 11:32 CDT
Canadian officials warn there's a possibility a small quantity of bottles labeled as containing the medication Rofact may, in fact, contain another drug.
Health Canada said some bottles of one lot of Rofact -- an antibiotic manufactured by Valeant Canada that's used to treat tuberculosis and some other infections -- might actually contain the drug clonazepam due to a production error. The affected lot number of Rofact is 8K5467 and the Drug Identification Number is 00343617.
Clonazepam is an anti-epileptic medication and has sedating properties.
Consumers who have Rofact (rifampin) at home are advised to check their bottle of medication and confirm that they have the correct, prescribed drug,
Health Canada said, explaining that Rofact 300 mg are hard capsules, brown and dark red in color, and the clonazepam pills are orange, round tablets.
People who suspect they might have been mistakenly taking clonazepam instead of Rofact at any time since the middle of December should contact their physician or their public health nurse to obtain the proper medication and treatment advice.
However, patients should not stop taking their prescription until directed by their physician,
the federal agency said. Some patients who suspect that they have mistakenly received clonazepam may need to be gradually taken off the drug to avoid withdrawal symptoms under the supervision of their physician.
Source: United Press International
Related Articles
- Owensboro Medical Health System Announces Results of Its 'Modified Dutch Auction' Tender Offer
- HealthCore Responds to Need for Real-world Health Outcomes Information on Drugs and Devices with Physician Network and Prospective Effectiveness Research
- Aetna Signs Contract With Orlando Health Physicians
- SXC Health Solutions Corp. Commences Exchange Offer For Shares Of National Medical Health Card Systems, Inc.
- Bright Health Physicians of PIH Selects HealthTrio's Enterprise Application Solution As Their System of Choice
- Owensboro Medical Health System Selects MedAssets for Supply Chain Solutions
- Insite Files New Drug Submission With Health Canada
- Link Between Oral, Medical Health to Be Examined at New Delta Dental of Minnesota Council Meeting
- National Medical, Health Care and Public Health Groups Take Challenge of Clean Air Mercury Rules to Higher Court
- Consumers Perceive Strong Link Between Oral and Medical Health; More Than One-Third Sustain Long-Term Relationships With Their Dentist, MetLife Study Shows
 |
 |
User Comments (0)
RSS Feeds